sodium (E)-5-oxo-1-(4-sulfonatophenyl)-4-((4-sulfonatophenyl)diazenyl)-4,5-dihydro-1H-pyrazole-3-carboxylate-D4; 1-(4-SULFOPHENYL)-3-CARBOXY-4-(4- SULFOPHENYL)AZO-5-PYRAZOLONE, TRISODIUM SALT-D4; 1310 Yellow-D4; 1409 Yellow-D4; 1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[(4-sulfophenyl)azo]-, trisodium salt-D4; 1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[(sulfophenyl)azo]-, trisodium salt-D4; 1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[2-(4-sulfophenyl)diazenyl]-, sodium salt (1:3)-D4; 3-Carboxy-5-hydroxy-1-p-sulfophenyl-4-p-sulfophenylazopyrazole trisodium salt-D4; 4,5-Dihydro-5-oxo-1-(4-sulfophenyl)-4-[(4-sulfophenyl)azo]-1H-pyrazole-3-carboxylic acid, trisodium salt-D4; 5-hidroxi-1-(4-sulfofenil)-4-(4-sulfofenilazo)pirazol-3-carboxilato de trisodio-D4; 5-Hydroxy-1-(4-sulfophenyl)-4-(4-sulfophenylazo)pyrazole-3-carboxylate de trisodium-D4; 5-Hydroxy-1-p-sulfophenyl-4-(p-sulfophenylazo)pyrazole-3-carboxylic acid, trisodium salt
Tartrazine-d4 is a fully characterized chemical compound used as a reference standard of API Tartrazine. The standard offered is compliant with regulatory guidelines. Tartrazine-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
Related products
Tartrazine Impurity 1 Disodium Salt
M.F. C₁₂H₉N₃O₆S₂; ₂Na
M.W. 355.34; 2(22.99)
CAT# AR-T03593
CAS# 56120-28-6